West Pharmaceutical Services, Inc.

WST Healthcare Medical Instruments & Supplies

West Pharmaceutical Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 billion, up 6.25% from fiscal 2024.

Revenue
+8.69%
EPS
+56.7%
Free cash flow
+12.3%
Total debt
+0.10%

Quarter to September 2026, against a year earlier

398.93 6.45 +1.64%
Market cap
$27.3B
P/E
43.8×
Fwd P/E
48.1×
Dividend yield
0.22%
F-score
8/9
Altman Z
13.89
Beneish M
−2.79
Dividend safety
100/100

West Pharmaceutical Services, Inc. (WST) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, West Pharmaceutical Services, Inc. (WST) trades at a P/B ratio of 9.3×. Over the past ten years it has ranged from 3.6× (February 2015) to 17.1× (September 2021); the current reading is higher than 73% of that period. That is above the Medical Instruments & Supplies industry median of 2.3× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 6.3× (29.74%)
FY2024 8.9× (0.87%)
FY2023 9.0× 38.44%
FY2022 6.5× (56.53%)
FY2021 14.9× 32.35%
FY2020 11.3× 59.66%
FY2019 7.1× 36.29%
FY2018 5.2× (9.69%)
FY2017 5.7× 4.18%
FY2016 5.5× 30.22%

Quarterly newest first

Period P/B ratio Change
Sep 2026 8.8× 3.45%
Jun 2026 8.5× 40.86%
Mar 2026 6.0× (3.65%)
Dec 2025 6.3× 0.91%
43 more quarters

Against its own ten years

Low 3.6× High 17.1×
Ten-year median 7.0×
Current reading's percentile 71

P/B ratio against peers

Company P/B ratio
COO The Cooper Companies, Inc. compare 1.5×
ALC Alcon compare 1.7×
MDLN Medline Inc. compare 1.8×
BAX Baxter International Inc. compare 2.0×
BDX Becton, Dickinson and Company compare 2.4×
ALGN Align Technology, Inc. compare 2.7×
SOLV Solventum Corporation compare 3.1×
RMD ResMed Inc. compare 5.7×
WST West Pharmaceutical Services, Inc. 9.3×
Medical Instruments & Supplies industry median 2.3×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on WST